Mariette Boerstoel Streefland
SVP, Worldwide Patient Safety Office – Bristol Myers Squibb

‘Leveraging GenAI with Key Partners for Enhanced Safety and Efficiency’

Felix Arellano
Global Head of Drug Safety – Roche

‘From Planning to Launch: How to Implement a New Safety Database and Maximize ROI’

Hans van Leeuwen
Global Head of Regulatory Operations – Astellas

‘Achieving Interoperable Safety and Regulatory Platforms’

Julie Thomas
Vice President, Global Medical Safety Operations – J & J

‘LifeSphere NavaX: Driving Greater Value with GenAI’

Smarter, Faster Literature Management

Transform medical literature screening with cutting-edge GenAI automation.

Download Checklist

ROI Calculator

Smarter, Faster Literature Management

Transform medical literature screening with cutting-edge GenAI automation.

Download Checklist

ROI Calculator

LifeSphere® Technology is trusted by these industry leaders:

Literature Intelligence

Literature Intelligence is our system-agnostic, GenAI-powered solution for literature intake and assessment, purpose-built to automate workflows for increased efficiency and data accuracy.

Unmatched Efficiency

Cut literature screening from days to minutes by replacing repetitive, labor-intensive manual processes with powerful, end-to-end GenAI-powered automation.

Top-Quality Compliance

Ensure consistent compliance by eliminating human-error, fatigue, and bias when working to meet regulatory requirements.

Smarter Literature Management

Harness technology to retrieve literature data swiftly and effortlessly, lighten workloads, and shift focus to higher-value activities.

Overhead Reduction

Lower total cost of ownership through a scalable cloud solution that offers system-agnostic integration with drug safety systems.

Features

Deliver real value with Literature Intelligence.

Advanced Automation

Leverage cutting-edge, production-ready AI/ML and GenAI automation capabilities that lead to major efficiencies, reduced errors, and improved decision-making.

System-Agnostic Integration

Ensure seamless interoperability with existing safety systems to optimize workflows and enable more seamless data flow without disruption.

API integration with Global Databases

Enable easy, automated literature ingestion and de-duplication from PubMed, Medline, and Embase, for comprehensive and accurate data flow.

Enhanced Literature Processing

Automate de-duplication and ICSR relevancy assessment to process large volumes of literature more efficiently and minimize manual intervention.

Integration with Preferred Full-Text Providers

Enhance data extraction and in-depth analysis of the full-text articles with GenAI for faster and more accurate insights.

Tailored Workflows

Gain the flexibility to meet specific organizational needs while ensuring full compliance with global regulatory standards.

GenAI-powered Modular Safety Solutions

Cutting-Edge capabilities. Seamless integration. Limitless potential.

Learn More

GenAI-powered Modular Safety Solutions

Cutting-Edge capabilities. Seamless integration. Limitless potential.

Learn More

Resources

Learn more about our collaborative partnership with customers.

"*" indicates required fields

Get started!

First Name*

Last Name*

Email*

Job Title*

Company Name*

HQ Country*

Area of Interest*

Purchase Timeframe*

Comments

This field is for validation purposes and should be left unchanged.

Literature IntelligenceMladen Prenc2025-02-13T12:47:28+00:00

ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 500 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.

Quick Links

Follow Us